Y-Intercept (HK)’s Axsome Therapeutics AXSM Stock Holding History

Y-Intercept (HK)’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.61M	Buy	+22,923	New	+$4.97M	0.11%	247
2026 Q1	–	Sell	-34,854	Closed	-$6.37M	–	1552
2025 Q4	$6.37M	Buy	34,854 +7,827	+29%	+$1.09M	0.14%	154
2025 Q3	$3.28M	Sell	27,027 -3,613	-12%	-$407K	0.08%	364
2025 Q2	$3.2M	Buy	30,640 +17,895	+140%	+$1.89M	0.08%	388
2025 Q1	$1.49M	Buy	+12,745	New	+$1.45M	0.1%	263
2024 Q4	–	Sell	-7,958	Closed	-$715K	–	1180
2024 Q3	$715K	Sell	7,958 -3,617	-31%	-$316K	0.04%	598
2024 Q2	$932K	Buy	+11,575	New	+$857K	0.05%	519
2024 Q1	–	Sell	-11,285	Closed	-$898K	–	1363
2023 Q4	$898K	Buy	+11,285	New	+$754K	0.08%	353
2022 Q3	–	Sell	-7,715	Closed	-$295K	–	960
2022 Q2	$295K	Buy	7,715 +941	+14%	+$29.8K	0.04%	590
2022 Q1	$280K	Buy	+6,774	New	+$210K	0.06%	475
2021 Q3	–	Sell	-3,634	Closed	-$245K	–	643
2021 Q2	$245K	Buy	+3,634	New	+$218K	0.06%	476
2021 Q1	–	Sell	-6,637	Closed	-$553K	–	620
2020 Q4	$553K	Buy	+6,637	New	+$496K	0.23%	128

Other funds holding AXSM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

BWP

Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

TAM

Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

Cannon Advisors Charlotte, North Carolina $164M AUM 30.34% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

HCM

Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return

Y-Intercept (HK)'s AXSM Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 22,923 shares worth $5.61M. The stake represents 0.11% of the portfolio and ranks #247 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in AXSM as recently as Q4 2025.

Y-Intercept (HK) first reported a position in AXSM in Q4 2020 and has held it in 12 quarters since. The position peaked at $6.37M in Q4 2025. 38 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Y-Intercept (HK) held 22,923 shares of Axsome Therapeutics worth $5.61M as of Q2 2026.
Axsome Therapeutics was a new Y-Intercept (HK) position in Q2 2026.
Axsome Therapeutics made up 0.11% of Y-Intercept (HK)'s portfolio in Q2 2026, its #247 holding.
Y-Intercept (HK) first reported a position in Axsome Therapeutics in Q4 2020 and has held it in 12 quarters since.
Y-Intercept (HK)'s Axsome Therapeutics position peaked at $6.37M in Q4 2025.
38 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.